The board of directors of China NT Pharma Group Company Limited announced that Mr. Pang Wing Hong (?Mr. Pang?) tendered his resignation (the ?Resignation?) as the company secretary of the Company, the authorised representative of the Company (the ?Authorised Representative?) under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ?Stock Exchange?) (the ?Listing Rules?) and the agent for the acceptance of service of process and notices on behalf of the Company in Hong Kong under Rule 19.05(2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (the ?Process Agent?) with effect from 31 December 2023. Mr. Pang confirmed that he has no disagreement with the Board and there are no circumstances related to his Resignation which need to be brought to the attention of the Stock Exchange and the shareholders of the Company. The Board is also announced that Mr. Cheng Cheung King (?Mr. Cheng?) has been appointed in replacement of Mr. Pang as the company secretary of the Company the Authorised Representative and the Process Agent with effect from 31 December 2023.

Mr. Cheng, aged 34, holds a Bachelor's degree in Accounting from the University of Adelaide in Australia and a Master degree of Corporate Governance from The Hong Kong Polytechnic University. Mr. Cheng is a certified public accountant of CPA Australia and an associate member of both the Chartered Governance Institute and The Hong Kong Chartered Governance Institute. With over 10 years of experience in the fields of accounting, auditing, and company secretarial work, Mr. Cheng has held various senior positions in the past 5 years, including finance manager and financial controller in a Main Board listed company and a Pre-IPO company, respectively.